Who are the winners and losers of the US-Iran deal?

The tentative US-Iran deal to end the latest Middle East flare-up arrives at a critical juncture, where regional brinkmanship and global energy markets intersect. Beyond the immediate humanitarian relief for Gazans and the families of the 120-plus hostages still held by Hamas, the agreement’s real stakes lie in whether it can arrest the broader drift toward a wider regional war. Israel’s retaliatory strikes on Iranian soil had already pushed the envelope of direct confrontation; if this deal sticks, it may signal that even the most combustible alliances—Tehran backing proxies like Hezbollah and the Houthis, Washington backing Israel—can still find off-ramps. For Europe, the accord offers a reprieve from another winter of energy insecurity, as Iranian oil could re-enter global markets just as winter demand peaks. For China and Russia, meanwhile, it represents a minor setback: both have courted Iran as a partner in their parallel efforts to erode US influence in the Middle East, and any détente between Washington and Tehran chips away at their leverage. Yet the deal’s durability is uncertain. Hardliners in both Tehran and Jerusalem have incentives to sabotage it—Tehran to placate its Revolutionary Guard, Jerusalem to preempt any perception of weakness. The text’s specifics remain murky, but the most consequential omission may be the absence of any enforceable mechanism to halt Iranian uranium enrichment or the flow of weapons to groups like Hamas. If Iran resumes enrichment at pre-2015 levels, or if Israel resumes targeted strikes on Iranian nuclear sites, the ceasefire could collapse within months. The deal’s success hinges on whether Washington can sell it to a skeptical Israeli government while persuading Iran’s supreme leader that the economic relief offered outweighs the strategic costs of reining in regional proxies. In the longer term, the accord could accelerate a subtle shift in Middle East alliances, nudging Gulf states like Saudi Arabia and the UAE toward deeper normalization with Israel—not out of affection, but as a hedge against an unreliable US patron. It may also embolden Iran to test the limits of its newfound détente, probing whether Washington will tolerate continued support for militias in Iraq or Syria. For now, the deal buys time, but the region’s history suggests time is the one commodity neither side has in abundance.